SCHEMBL14201631

SCHEMBL14201631

C=CCN1CCC(NC)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CARM1 Q86X55 2/20 0.32
PRMT6 Q96LA8 2/20 0.32
PRMT1 Q99873 1/20 0.32
PRMT8 Q9NR22 1/20 0.32
HRH3 Q9Y5N1 2/20 0.31
ADRA2A P08913 2/20 0.31
ADRA2B P18089 2/20 0.31
ADRA2C P18825 2/20 0.31
MAPT P10636 2/20 0.31
LMNA P02545 1/20 0.31
DRD2 P14416 1/20 0.31
HTR2A P28223 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
OPRK1 P41145 1/20 0.31
TEAD1 P28347 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9545500 0.90 SIGMAR1 (0.36) OPRM1OPRD1SIGMAR1HRH3DRD2
SCHEMBL9034363 0.78 CARM1 (0.32) CARM1PRMT6PRMT1PRMT8
SCHEMBL3343259 0.78 ADH1B (0.48) OPRM1OPRD1SIGMAR1DRD2HTR2A
SCHEMBL5789303 0.77 CARM1 (0.34) CARM1PRMT6PRMT1PRMT8HRH3
SCHEMBL82611 0.77 CARM1 (0.48) OPRM1OPRD1SIGMAR1CARM1PRMT6
SCHEMBL3343255 0.76 HRH3 (0.31) OPRM1OPRD1SIGMAR1HRH3TEAD1
SCHEMBL24243286 0.75 OPRD1 (0.38) OPRM1OPRD1SIGMAR1HRH3ADRA2A
SCHEMBL4502992 0.75 SIGMAR1 (0.35) OPRM1OPRD1SIGMAR1HRH3ADRA2A
SCHEMBL4959156 0.75 SIGMAR1 (0.35) OPRM1OPRD1SIGMAR1HRH3ADRA2A
SCHEMBL579037 0.75 SMN1; SMN2 (0.43) CARM1PRMT6PRMT1PRMT8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF WYETH (US) 2008-04-24 US disclosed
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF WYETH (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF HSP90AB2P, HSP90AB1, HSP90AA1 OPRM1 4593/4885OPRD1 4531/4885SIGMAR1 3342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.